Literature DB >> 27847146

Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.

Youssef Kouidrat1, Ahmad Zaitouni2, Ali Amad3, Momar Diouf2, Rachel Desailloud2, Gwenole Loas4, Jean-Daniel Lalau2.   

Abstract

AIM: Although diabetes-related erectile dysfunction (ED) has many etiological factors, little is known about the putative pathophysiological role of advanced glycation end products (AGEs). Skin autofluorescence is a noninvasive marker of AGEs. Recent studies have evidenced a relationship between skin autofluorescence and several complications of diabetes. We hypothesized that AGEs (assessed by skin autofluorescence) are associated with ED in diabetes patients.
METHODS: Between March 2014 and April 2015, 42 patients with type 1 diabetes (T1D) and 44 patients with type 2 diabetes (T2D) were consecutively enrolled in a descriptive, cross-sectional study and compared to 54 healthy controls. ED was evaluated via the 5-item version of the International Index of Erectile Function (IIEF-5). Skin autofluorescence was measured on the volar aspect of the arm with an AGE-Reader.
RESULTS: Patients with diabetes had a mean±standard deviation age of 50±15 and a mean duration of diabetes of 16±12years. Skin autofluorescence was strongly and significantly correlated with the IIEF-5 score in the T1D subgroup (r=-0.52; P=0.004), the T2D subgroup (r=-0.32; P<0.03) and in the whole group of diabetic patients (r=-0.49; P<0.0001). In multivariate analyses that controlled for potentially confounding clinical and biochemical factors, only skin autofluorescence was still significantly correlated with the IIEF-5 score (P<0.0001). A receiver operating characteristic analysis revealed that a skin autofluorescence value ≥3.2AU determined severe ED with a sensitivity of 60% and a specificity of 87% in diabetic patients.
CONCLUSION: Skin autofluorescence is significantly associated with ED in diabetes, independently of classical confounding factors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced glycation end product; Cardiovascular risk; Diabetes; Erectile dysfunction; Microangiopathy; Skin autofluorescence

Mesh:

Substances:

Year:  2016        PMID: 27847146     DOI: 10.1016/j.jdiacomp.2016.10.026

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  1 in total

1.  Erectile Dysfunction in Individuals with Type 1 Diabetes is Associated with Long-term Metabolic Control and Diabetic Complications: A Cross-Sectional Study.

Authors:  Mikołaj Kamiński; Michał Kulecki; Paweł Lachowski; Dominika Kasprzak; Ania Kulczycka; Maria Kozłowska; Daria Klause; Aleksandra Uruska; Mateusz Michalski; Dorota Zozulińska-Ziółkiewicz
Journal:  Int J Angiol       Date:  2022-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.